Skip to content

Revised Labeling for ADX Amphetamine/Methampheta

by Abbott Laboratories 510(k)

Active United States

510(k) K880013

Overview

This is an enzyme immunoassay device for the detection of amphetamine. It is a Class II medical device designed for clinical toxicology applications.

The device is manufactured by Abbott Laboratories and received FDA 510(k) clearance with number K880013 on March 1, 1988. It is regulated under product code DKZ and regulation number 862.3100. The device is not specified as single-use or reusable, and no information regarding sterility, MRI safety, or storage conditions is provided.

AI-generated from registry data, 22 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK880013 Date1 Mar 1988ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 22 Oct 2026)

Specification

510(k)

510(k) Number
FDA Product Code
DKZ
Device Class
Class II
Regulation
21 CFR Part 862.3100
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Other devices from Abbott Laboratories

See all devices from Abbott Laboratories →

Questions

  • What is the ADX Amphetamine/Methamphet device used for?

    This device is an enzyme immunoassay designed for the detection of amphetamine in clinical toxicology applications. It helps laboratories identify amphetamine presence in patient samples for diagnostic purposes.

  • Is the ADX Amphetamine/Methamphet device single-use or reusable?

    The device information does not specify whether it is designed for single-use or reusable applications. This detail should be confirmed in the product labeling or by contacting the manufacturer directly for specific usage instructions.

  • What regulatory approvals does the ADX Amphetamine/Methamphet device have?

    The device received FDA 510(k) clearance with number K880013 on March 1, 1988. It is classified as a Class II medical device under product code DKZ and regulation number 862.3100, designed for clinical toxicology applications.

  • Are there different models or sizes available for the ADX Amphetamine/Methamphet device?

    The device data does not specify different models or sizes. The information provided refers to a single device type for amphetamine detection. For specific model variations, additional product information would be required.